GlassScriptPhysician profile
Megan E Bennett
NPI 1235681123
$8,344.32
in general payments reported to CMS, 2019-2025
50 companies · $1,584 in 2025
The $1,584 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,523 · 2022: $2,173 · 2023: $1,495 · 2024: $1,569 · 2025: $1,584.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,570 · Education: $78.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,570.02 |
| Education | $78.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,210.40 | 2021-2025 | |
| Novo Nordisk INC | $985.63 | 2021-2025 | Ozempic, Rybelsus, Tresiba |
| Lilly USA, LLC | $818.77 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $560.31 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Amgen INC. | $530.28 | 2021-2025 | Otezla, Repatha, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $499.17 | 2021-2025 | |
| Pfizer INC. | $400.99 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $372.98 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $352.78 | 2021-2023 | Glassia |
| Otsuka America Pharmaceutical, INC. | $352.52 | 2021-2025 | Rexulti, Abilify Asimtufii |
| Abbott Laboratories | $248.27 | 2021-2023 | Freestyle Libre 3, Freestyle Libre 2 |
| Sanofi-Aventis U.S. LLC | $186.37 | 2021-2022 | |
| Esperion Therapeutics, INC. | $178.18 | 2021-2025 | Nexletol |
| Harmony Biosciences LLC | $130.08 | 2023-2025 | Wakix |
| Astellas Pharma US INC | $117.95 | 2021-2024 | Veozah |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.